Cell membrane proteins hide secret gateways that can be used to modify cell behavior. This has been demonstrated in a study ...

To have any impact, patient engagement needs to start with the drug development pathway, not at the point of licensing. That’s especially true in the rare disease space, where the unmet need is ...

It may be disturbing to characterize human bodies in such commodifying terms, but the unavoidable reality is that human ...

Based on Intelligencia AI’s comprehensive, proprietary database of over 20,000 industry-sponsored, interventional oncology clinical programs (around 12,400 clinical trials), recent insights highlight ...

The results are available online to support the development of new ... coordinator of the GPCR Drug Discovery Research Group within the Biomedical Informatics Research Program (GRIB) at the ...

| Project Optimus is changing the landscape of oncology drug development by redefining dose optimization standards. Learn how ...

The co-development of molecular markers ... correlates of the clinical efficacy of a novel drug by studying the target, its pathway and other related molecules, it might become possible to use ...

THIO has gained its generic name and preclinical data on a different form of the cancer drug suggests it could improve chemotherapy efficacy.

The plan includes an accelerated approval pathway that sets as co-registrational ... into big-picture policy questions going beyond drug development in rare diseases and other indications ...